Experiment 1227407
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | KAHN,JO: KAPLAN,LD: GAMBERTOGLIO,JG: BREDESEN,D: ARRI,CJ: TURIN,L: KOBORT,T: WILLIAMS,RL: LIFSON,JD: VOLBERDING,PA:. (1990). THE SAFETY AND PHARMACOKINETICS OF GLQ223 IN SUBJECTS WITH AIDS AND AIDS-RELATED COMPLEX: A PHASE I STUDY.. 4(12) |
| Amount utilized | |
| Compound isolated | |
| Disease | 18 PATIENTS, 10 WITH AIDS AND 8 WITH ARC WERE ENROLLED IN THIS PHASE 1 STUDY. THE ONLY NOTABLE TOXICITY OBSERVED WAS A NEUROLOGICAL TOXICITY WITH CLINICAL FEATURES RESEMBLING ACUTE DISSEMINATED ENCEPHALOMYELITIS. THIS WAS OBSERVED IN 1 PATIENT. PATIENTS SHOWED NO CHANGES IN CD4+ LYMPHOCYTE POPULATIONS OR HIV ANTIGEN LEVELS. |
| Dose amount | 1-36 MCG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | KG |
| Dose expression | DOSE |